Category Archives: Tysabri

Featured Stories

Metal-on-Metal Hip Implant Lawyer Takes Issue with Statements Made by DePuy Orthpaedics Official During FDA Meeting

An attorney with a national law firm that represents victims of alleged metal-on-metal hip implant injuries has expressed dismay at some statements made last week regarding the regulation of all-metal hip replacement devices by an official with DePuy Orthopaedics. According to Daniel Burke, Senior Litigation Counsel at Parker ...

Read More

Actos, Avandia May Up Risk for Diabetic Macular Edema

A newly published study is raising concerns that patients who take Actos or Avandia may face an increased risk of developing diabetic macular edema, an eye disorder that can result in vision loss. The study, published in the Archives of Internal Medicine, found that type 2 diabetics who use thiazolidinediones, ...

Read More

Study Finds SSRI Antidepressant Side Effects Outweigh Their Benefits

A new study is raising more concerns about the safety of commonly used antidepressants, including selective serotonin reuptake (SSRI) inhibitor antidepressants. Investigators who conducted the study, which is published in the journal Frontiers in Psychology, posit that increased knowledge of the negative effects of SSRIs and other antidepressants could reduce ...

Read More

Pradaxa Named in Most FDA Adverse Event Reports for Deaths, Hemorrhage, Kidney Failure and Stroke

The controversial blood thinner, Pradaxa, surpassed all other drugs monitored by the U.S. Food & Drug Administration (FDA) in adverse event reports made to the agency last year. According to the Institute for Safe Medicine Practices’ (ISMP) latest QuarterWatch report, Pradaxa also topped the list for reports of deaths, ...

Read More

Image Source: saidaonline.com

Sleep Aids Can Increase Alzheimer’s Risk

A new study has found that over-the-counter sleeping aids and anti-allergy medicines can increase the risk of Alzheimer’s disease.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Johnson & Johnson Facing More Metal-on-Metal Hip Implant Woes, as DePuy Pinnacle Complaints Rise

Having already spent around $3 billion on its DePuy Orthopaedics ASR hip implant recall, Johnson & Johnson is facing another potential debacle involving a metal-on-metal version of its Pinnacle Hip Replacement System. According to a report from Reuters, Johnson & Johnson and its DePuy unit already face some 1,600 metal-on-metal ...

New Research Links Multiple Sclerosis Drug Tysabri to Fatal Brain Infection

A newly published report indicates that patients taking the multiple sclerosis drug Tysabri have a higher risk of developing a potentially fatal brain infection than previously thought. German and French researchers found that Tysabri (natalizumab), used to treat patients with … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Tysabri |

Anti-Drug Antibodies Allegedly Lead to MS Patient’s Death

A Swedish woman diagnosed with multiple sclerosis (MS) appears to have died after developing anti-Tysabri (natalizumab) antibodies, according to emerging research. The woman tested with what MedPage Today described as “significant neurological abnormalities” and very high titers of antibodies against … Continue reading

Posted in Pharmaceuticals, Tysabri |

New Tysabri PML Risk Factor Identified

The Food and Drug Administration has identified a new risk factor which could lead to the life-threatening brain infection known as progressive multifocal leukoencephalopathy (PML) associated with the use of the drug Tysabri. Tysabri is prescribed as a “last resort” … Continue reading

Posted in Pharmaceuticals, Tysabri |

FDA Announces Tysabri Label Update

Last week, the U.S. Food & Drug Administration (FDA) announced it was updating the label of < "http://www.yourlawyer.com/topics/overview/tysabri">Tysabri (natalizumab) to include additional information about the risk of progressive multifocal leukoencephalopathy (PML), a rare but serious brain infection. According to a … Continue reading

Posted in Pharmaceuticals, Tysabri |

Tysabri Label Modified to Include More Brain Infection Data

< "http://www.yourlawyer.com/topics/overview/tysabri">Tysabri, the multiple sclerosis drug marketed by Biogen Idec Inc. and Elan Corp is having its label updated to include new data about the incidence of progressive multifocal leukoencephalopathy, or PML, a rare brain infection. According to a report … Continue reading

Posted in Tysabri |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.